| Dr Brenda A Snowman, MD | |
|
2550 Business Park Dr Ne, Cleveland, TN 37311-6503 | |
| (423) 339-8881 | |
| (423) 464-6126 |
| Full Name | Dr Brenda A Snowman |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2550 Business Park Dr Ne, Cleveland, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235117250 | NPI | - | NPPES |
| 0157720 | Other | TN | BLUE CROSS BLUE SHIELD |
| Q011934 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD023514 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brenda A Snowman, MD 2550 Business Park Dr Ne, Cleveland, TN 37311-6503 Ph: (423) 339-8881 | Dr Brenda A Snowman, MD 2550 Business Park Dr Ne, Cleveland, TN 37311-6503 Ph: (423) 339-8881 |
News Archive
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Researchers at the Stanford University School of Medicine have identified mutations in several new genes that might be associated with the development of spontaneously occurring cases of the neurodegenerative disease known as amyotrophic lateral sclerosis, or ALS.
No one knows how many newborns are dying each year due to antibiotic resistant infections, because of a lack of funding to research the issue fully, Professor Mike Sharland from St George's, University London said.
There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that its investigational new drug application (IND 109196) for its novel drug mibefradil has been accepted by the Food and Drug Administration (FDA).
› Verified 4 days ago
Steven D Wolf, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2301 N Ocoee St, Suite A, Cleveland, TN 37311 Phone: 423-339-1400 Fax: 423-339-9951 | |
Dr. May Nokkaew, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2550 Business Park Dr Ne, Cleveland, TN 37311 Phone: 423-339-8881 | |
Cynthia Mcintyre Harris, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2417 Chambliss Ave Nw, Cleveland, TN 37311 Phone: 423-559-9771 Fax: 423-614-6872 | |
Alexandra Kitchens, APRN Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2301 N Ocoee St Ste A, Cleveland, TN 37311 Phone: 423-339-1400 Fax: 423-339-9950 | |
John Manley Powell, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2301 N Ocoee St, Cleveland, TN 37311 Phone: 423-339-1400 Fax: 423-339-9950 | |
Christopher Noel Mullin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2301 N Ocoee St, Cleveland, TN 37311 Phone: 423-339-1400 Fax: 423-339-9950 |